Adjuvant Capital

New York City, New Yorkadjuvantcapital.com

Overview

Adjuvant Capital is a life sciences venture capital firm that invests in companies developing technologies for high-burden public health challenges in low- and middle-income countries . It focuses on neglected, high-burden, and emerging infectious diseases, maternal, newborn, and child health challenges, reproductive and sexual health and nutrition .

Year Founded

2018

Portfolio Companies

Website

adjuvantcapital.com

Investments

Adjuvant Capital investments
Company	Date	Stage	Lead
VitriVax, Inc.	Oct 2025	Series B	Lead
Curevo Vaccine	Mar 2025	Series B	Co-investor
Memo Therapeutics AG	May 2024	Series C Extension	Co-investor
LimmaTech Biologics	Feb 2024	Series A Extension	Co-investor
Memo Therapeutics AG	Nov 2023	Series C	Co-investor

View all investments

Key People

Charlie Petty

Co-Founder

Glenn Rockman

Founder and Managing Partner

Gerard Cunningham

Operating Partner

Mark Sullivan AO

Venture Partner

Kabeer Aziz

Partner

Abrar Haque

Investor

Giulia Balconi

Life Sciences Venture Capital

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

FAQ

Firmographic Details

HeadquartersNew York City, New York

Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?